Regenerative Therapies · Patient Guide
Understanding Exosomes and Healing
A plain-language look at what exosomes are, what the science does and does not yet show, and how they are being studied as a less-invasive avenue for chronic pain.
Educational information only. This page is not medical advice, and exosome therapy is investigational and not FDA-approved.
The basics
What exosomes actually are
Every cell in your body is constantly sending out tiny packages. Exosomes are among the smallest of these: microscopic bubbles, far too small to see, that cells release to communicate with one another.
Think of them as messenger packets. Inside, a cell packs proteins, growth factors, and genetic instructions (small pieces of genetic material called RNA), then releases them to reach other cells nearby or elsewhere in the body.
When a neighboring cell receives one of these packets, it can change how it behaves: calming down, ramping up repair activity, or coordinating with the cells around it. Because they carry a cell’s signals without being a whole living cell themselves, researchers are studying exosomes as a possible way to deliver helpful messages to injured or inflamed tissue.
The science
Why scientists think they may support healing
Healing is, in large part, a communication problem. For tissue to repair itself, many different cells have to coordinate: quieting inflammation, clearing away damaged material, building new blood vessels, and laying down healthy tissue.
Exosomes are one of the body’s own tools for that coordination. In laboratory and early research settings, exosomes (often collected from stem cells) have appeared to:
- help calm excessive inflammation,
- signal the body's repair cells to become more active,
- support the growth of new blood vessels that feed healing tissue.
The appeal is that exosomes may carry many of the beneficial signals associated with stem cells while being simpler to handle and study. That is why they have become such an active area of regenerative-medicine research.
The evidence
What the evidence shows today, honestly
The honest summary is this: exosome research is genuinely promising, and it is still early.
Most of what we know so far comes from laboratory work, animal research, and small early-phase human studies. The larger, rigorous clinical trials, the kind needed to prove that a therapy is both safe and effective, are still underway or have not yet been completed for most uses.
That does not mean exosomes do not work. It means the science has not yet reached the level of proof required for approval. Anyone who tells you the outcome is guaranteed is going well beyond what the current evidence supports.
Responsible use of exosomes today happens under physician supervision, often within research or structured data-collection programs designed to add to what the medical community knows.
Chronic pain
Where this fits for chronic pain
Chronic pain is complicated, and not everyone is a good candidate for surgery. Some people have other medical conditions that make an operation riskier. Others simply want to explore less-invasive options before considering something as significant as spinal surgery.
For these patients, physicians sometimes explore regenerative approaches, including exosome-based therapies, as a possible avenue, in some cases as an alternative to consider alongside spinal surgery rather than instead of it. Regenova works with Dynacord, a research organization advancing the science of stem cell-derived exosomes. Whether any such approach is appropriate is a decision made entirely by you and your treating physician.
To be clear: this is a decision you and your physician make together. Exosome therapy is not a proven replacement for surgery, and it is not right for everyone. A qualified doctor evaluates your specific situation, explains the current state of the evidence, and helps you weigh the realistic options, including standard care and doing nothing.
Please read this carefully
Safety and regulatory facts you should know
It is not FDA-approved
As of today, the FDA has not approved any exosome product to treat any disease or condition, and it has publicly cautioned the public about unapproved exosome products marketed with unproven claims.
It is investigational
Exosome therapy is considered investigational, meaning it is still being studied. Its long-term safety and effectiveness are not yet fully established.
There are real, if uncommon, risks
As with any biologic product or injection, possible risks include infection, allergic or immune reactions, and the chance that the therapy simply does not help. Product quality and handling matter, which is one reason physician supervision is essential.
No one can guarantee results
Be cautious of any clinic or website that promises specific outcomes, “cures,” or guaranteed results. That kind of claim is a warning sign, not a selling point.
Informed consent comes first
In a responsible program you should receive clear written information about what is known, what is unknown, the risks, and the costs, and you should give informed consent before anything proceeds.
Our role
Where Regenova fits, and where it does not
Regenova does not provide exosome therapy and does not make treatment decisions. We are a technology and documentation platform that supports the relationship between you and a qualified physician.
What we do
- Connect patients living with chronic pain to physicians who evaluate whether a regenerative approach is appropriate for them.
- Provide an AI-assisted transcription and documentation system, built with our partner Lucas Health AI, so your doctor can spend more time listening to you and less time typing.
- Organize clinical information into structured, privacy-protected records that, with your consent, can ethically contribute to research that advances these therapies for everyone.
What we do not do
We do not prescribe, recommend, or deliver any specific treatment. Every clinical choice, whether exosome therapy, surgery, or another path, is made by your physician based on your individual needs and with your informed consent. Your privacy and your choices always come first.
Next steps
Questions to ask your doctor
If you are curious whether a regenerative approach could be relevant to you, these questions can help you and your physician have a clear, honest conversation.
- Am I a candidate for a regenerative approach, and why or why not?
- What does the current evidence actually show for my specific condition?
- What are the realistic risks, and what are my alternatives, including standard care or doing nothing?
- Is this being offered within a study or data-collection program, and what would that involve?
- What are the costs, and is any of this covered by my insurance?
- What outcome is realistic, and how will we know whether it is or is not working?
Who we work with
Our clinical and research partners
Regenova is a platform, and the work happens through trusted partners. Exosome science is advanced by dedicated researchers, and your care is documented by tools built for clinicians. You can learn more about each below.
A research organization advancing the science of stem cell-derived exosomes and how cells communicate. Their materials are for research use and are not FDA-approved for human use.
Visit dyna-cord.com ↗LLucas Health AIAn ambient AI medical scribe, built by providers for providers, that turns the clinical conversation into accurate documentation so your doctor can focus on you.
Visit lucashealth.ai ↗Important disclaimer. This page is provided by Regenova for general educational purposes only. It is not medical advice, a diagnosis, or a treatment recommendation, and it does not create a doctor-patient relationship. Exosome therapy is investigational and is not approved by the U.S. Food and Drug Administration to treat, cure, or prevent any disease or condition. Statements on this page have not been evaluated by the FDA. Individual results vary and are never guaranteed. Always consult a qualified, licensed healthcare provider about your specific condition before making any medical decision.